Collectively, these results confirmed that the deletion of Panx1 did not affect the infiltration of CD4+ and CD8+ T lymphocytes in the tumors, although the cytotoxic effect seemed to be insufficient to prevent the tumor progression in BPC‐Panx1−/− mice. This evidence concerns the gene CD4 and neoplasm.